{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:18:23Z","timestamp":1792059503906,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA094061"],"award-info":[{"award-number":["T32CA094061"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Since the onset of COVID-19, oncology practices across the US have integrated telemedicine (TM) and remote patient monitoring (RPM) into routine care and clinical trials. The extent of provider experience and comfort with TM\/RPM in treatment trials, however, is unknown. We surveyed oncology researchers to assess experience and comfort with TM\/RPM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between April 10 and June 1, 2022, we distributed email surveys to US-based members of the American Society of Clinical Oncology (ASCO) whose member records indicated interest or specialization in clinical research. We collected respondent demographic data, clinical trial experience, workplace characteristics, and comfort and experience with TM\/RPM use across trial components in phase I and phase II\/III trials. TM\/RPM was defined as clinical trial-related healthcare and monitoring for patients geographically separated from trial site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 141 surveys analyzed (5.1% response rate). Ninety percent of respondents had been Principal Investigators, 98% practiced in a norural site. Most respondents had enrolled patients in phase I (82%) and phase II\/III trials (99%). Across all phases and trial components, there was a higher frequency of researcher comfort compared to experience. Regarding remote care in treatment trials, 75% reported using TM, RPM, or both. Among these individuals, 62% had never provided remote care to trial patients before the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>COVID-19 spurred the rise of TM\/RPM in cancer treatment trials, and some TM\/RPM use continues in this context. Among oncology researchers, higher levels of comfort compared with real-world experience with TM\/RPM reveal opportunities for expanding TM\/RPM policies and guidelines in oncology research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyad237","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:47:14Z","timestamp":1691599634000},"page":"356-363","source":"Crossref","is-referenced-by-count":11,"title":["Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials"],"prefix":"10.1093","volume":"29","author":[{"given":"Morgan R L","family":"Lichtenstein","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-4229","authenticated-orcid":false,"given":"Laura A","family":"Levit","sequence":"additional","affiliation":[{"name":"Center for Research and Analytics, American Society of Clinical Oncology , Alexandria, VA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Schenkel","sequence":"additional","affiliation":[{"name":"Center for Research and Analytics, American Society of Clinical Oncology , Alexandria, VA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Center for Research and Analytics, American Society of Clinical Oncology , Alexandria, VA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola A","family":"Fashoyin-Aje","sequence":"additional","affiliation":[{"name":"Oncology Center of Excellence, U.S. Food and Drug Administration , Silver Spring, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suanna S","family":"Bruinooge","sequence":"additional","affiliation":[{"name":"Center for Research and Analytics, American Society of Clinical Oncology , Alexandria, VA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Kelley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke Cancer Institute and Medical Oncology, Duke University Medical Center, and Hematology-Oncology, Durham VA Medical Center , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh A","family":"Mailman","sequence":"additional","affiliation":[{"name":"NorCal CarciNET Community , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0968-8265","authenticated-orcid":false,"given":"Allison","family":"Magnuson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Rochester Medical Center , Rochester, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P","family":"Mirda","sequence":"additional","affiliation":[{"name":"Providence Medical Group Northern California Napa , CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Natesan","sequence":"additional","affiliation":[{"name":"University of North Carolina , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L","family":"Hershman","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"2024041017273655600_CIT0001","first-page":"1698","article-title":"Telemedicine for cancer care in the Time of COVID-19","volume-title":"JAMA Oncol","author":"Royce","year":"2020"},{"key":"2024041017273655600_CIT0002","article-title":"As telemedicine surges, will community health suffer","author":"Greene","year":"2020","journal-title":"Boston Review"},{"key":"2024041017273655600_CIT0003","first-page":"568","article-title":"Rethinking cancer clinical trials for COVID-19 and beyond","volume-title":"Nat Cancer","author":"Doherty","year":"2020"},{"key":"2024041017273655600_CIT0004","first-page":"SP330","article-title":"Telemedicine for cancer care: implementation across a multicenter community oncology practice","volume-title":"Am J Manag Care","author":"Patt","year":"2020"},{"key":"2024041017273655600_CIT0005","first-page":"e11","article-title":"Telemedicine in community cancer care: how technology helps patients with cancer navigate a pandemic","volume-title":"JCO Oncol Pract","author":"Patt","year":"2021"},{"key":"2024041017273655600_CIT0006","first-page":"933","article-title":"Optimizing the use of telemedicine in oncology care: postpandemic opportunities","volume-title":"Clin Cancer Res","author":"Knudsen","year":"2021"},{"key":"2024041017273655600_CIT0007","first-page":"540","article-title":"Telemedicine in cancer care","volume-title":"Am Soc Clin Oncol Educ Book","author":"Sirintrapun","year":"2018"},{"key":"2024041017273655600_CIT0008","volume-title":"Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health: Emergency Guidance for Industry, Investigators, and Institutional Review Boards","author":"U.S. Department of Health and Human Services FDA, (CDER) CfDEaR, (CBER) CfBEaR","year":"2020"},{"key":"2024041017273655600_CIT0009","volume-title":"Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic 2022.","author":"The European Medicines Agency, (GCP) GCP, IWG) IWGG, et al"},{"key":"2024041017273655600_CIT0010","first-page":"e1333","article-title":"Medical oncology patient perceptions of telehealth video visits","volume-title":"JCO Oncol Pract","author":"Granberg","year":"2021"},{"key":"2024041017273655600_CIT0011","first-page":"e31255","article-title":"The use of telemedicine in cancer clinical trials: connect-patient-to-doctor prospective study","volume-title":"JMIR Cancer","author":"Meghiref","year":"2022"},{"key":"2024041017273655600_CIT0012","first-page":"508","article-title":"Exploring Australian regional cancer patients\u2019 experiences of clinical trial participation via telehealth","volume-title":"J Telemed Telecare","author":"Lee","year":"2022"},{"issue":"0","key":"2024041017273655600_CIT0013","first-page":"1357633X211045586","article-title":"Patient satisfaction with telehealth consultations in medical oncology clinics: a cross-sectional study at a metropolitan centre during the COVID-19 pandemic","volume":"0","author":"Andrew","year":"2021","journal-title":"J Telemed Telecare"},{"key":"2024041017273655600_CIT0014","first-page":"e2220053","article-title":"Association of remote technology use and other decentralization tools with patient likelihood to enroll in cancer clinical trials","volume-title":"JAMA Netw Open.","author":"Adams","year":"2022"},{"key":"2024041017273655600_CIT0015","first-page":"250","article-title":"Socioeconomic disparities, financial toxicity, and opportunities for enhanced system efficiencies for patients with cancer","volume-title":"J Surg Oncol","author":"Abbott","year":"2017"},{"key":"2024041017273655600_CIT0016","first-page":"801","article-title":"The potential for health-related uses of mobile phones and internet with homeless veterans: results from a multisite survey","volume-title":"Telemed J E Health","author":"McInnes","year":"2014"},{"key":"2024041017273655600_CIT0017","first-page":"e9","article-title":"Internet and mobile technology use among urban African American parents: survey study of a clinical population","volume-title":"J Med Internet. Res","author":"Mitchell","year":"2014"},{"key":"2024041017273655600_CIT0018","first-page":"86","article-title":"Using Health Information Technology to reach patients in underserved communities: a pilot study to help close the gap with health disparities","volume-title":"Glob J Health Sci","author":"Ryan","year":"2015"},{"key":"2024041017273655600_CIT0019","first-page":"e29575","article-title":"Telehealth interventions and outcomes across rural communities in the United States: narrative review","volume-title":"J Med Internet Res","author":"Butzner","year":"2021"},{"key":"2024041017273655600_CIT0020","first-page":"68","article-title":"Extending oncology clinical services to rural areas of Texas via teleoncology","volume-title":"J Oncol Pract","author":"Sharma","year":"2012"},{"key":"2024041017273655600_CIT0021","first-page":"649","article-title":"Impact of the COVID-19 pandemic on oncology clinical research in Latin America (LACOG 0420)","volume-title":"JCO Glob Oncol","author":"Lara Gongora","year":"2021"},{"key":"2024041017273655600_CIT0022","first-page":"1320","article-title":"Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus","volume-title":"Ann Oncol","author":"Curigliano","year":"2020"},{"key":"2024041017273655600_CIT0023","first-page":"651","article-title":"International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials","volume-title":"J Thorac Oncol","author":"Smeltzer","year":"2022"},{"key":"2024041017273655600_CIT0024","first-page":"103","article-title":"The impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials","volume-title":"Curr Breast Cancer Rep","author":"Ndumele","year":"2021"},{"key":"2024041017273655600_CIT0025","first-page":"100339","article-title":"The impact of COVID-19 on cancer care and oncology clinical research: an experts\u2019 perspective","volume-title":"ESMO Open","author":"Sessa","year":"2022"},{"key":"2024041017273655600_CIT0026","first-page":"417","article-title":"Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey","volume-title":"JCO Oncol Pract","author":"Waterhouse","year":"2020"},{"key":"2024041017273655600_CIT0027","volume-title":"AGRICULTURE USDO: Rural-Urban Commuting Area Codes","author":"Service","year":"2020"},{"key":"2024041017273655600_CIT0028","volume-title":"Rural Health Research Center Data","author":"Center RHR","year":"2000"},{"key":"2024041017273655600_CIT0029","first-page":"e12587","article-title":"Telehealth models could be extended to conducting clinical trials-a teletrial approach","volume-title":"Eur J Cancer Care (Engl)","author":"Sabesan","year":"2018"},{"key":"2024041017273655600_CIT0030","first-page":"546","article-title":"Telehealth in oncology: ASCO Standards and Practice Recommendations","volume-title":"JCO Oncol Pract","author":"Zon","year":"2021"},{"key":"2024041017273655600_CIT0031","first-page":"155","article-title":"American Society of Clinical Oncology Road to Recovery Report: learning from the COVID-19 experience to improve clinical research and cancer care","volume-title":"J Clin Oncol","author":"Pennell","year":"2021"},{"key":"2024041017273655600_CIT0032","first-page":"e000924","article-title":"Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change","volume-title":"ESMO Open","author":"Lorusso","year":"2020"},{"key":"2024041017273655600_CIT0033","first-page":"245","article-title":"Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation","volume-title":"J Natl Cancer Inst","author":"Unger","year":"2019"},{"key":"2024041017273655600_CIT0034","first-page":"1843","article-title":"Telemedicine in cancer care beyond the COVID-19 pandemic: oncology 2.0","volume-title":"Curr Oncol Rep","author":"West","year":"2022"},{"key":"2024041017273655600_CIT0035","first-page":"1327","article-title":"Rethinking clinical trials reform during the COVID-19 pandemic","volume-title":"JAMA Oncol","author":"Nabhan","year":"2020"},{"key":"2024041017273655600_CIT0036","first-page":"121","article-title":"Telemedicine across the cancer care continuum: evidence and opportunities for clinical care, research, and policy","volume-title":"Cancer J","author":"Nekhlyudov","year":"2022"},{"key":"2024041017273655600_CIT0037","volume-title":"ASCO Position Statement: Telemedicine Cross-State Licensure","author":"American Society of Clinical Oncology"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/4\/356\/57210382\/oyad237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/4\/356\/57210382\/oyad237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T14:15:13Z","timestamp":1712758513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/4\/356\/7262961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,9,7]]},"published-print":{"date-parts":[[2024,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyad237","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,9,7]]}}}